{"id":"tp-51261","type":"article-newspaper","title":"Revelation Biosciences Posts $5.92 GAAP Loss Per Share in Q3 2026","author":"John Kim","publisher":"TOKENPOST Inc.","url":"https://www.tokenpost.com/news/business/51261","datePublished":"2026-11-08T01:51:29.000Z","dateModified":"2026-11-08T01:51:29.000Z","language":"en","abstract":"Cash and cash equivalents were $9.1 million on Sept. 30, 2026, compared with $10.7 million on Dec. 31, 2025.","section":"Business","references":[]}